The Scientific World Journal / 2014 / Article / Fig 3

Research Article

Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines

Figure 3

PARP-1 cleaved, Beclin-1, LC3I, and LC3II protein expression analysis by western blotting in Huh7 and HepG2 cell lines after treatment with doxorubicin (0.85 μM) and tacrolimus (0.052 μM) and cotreatment (0.42 μM dox plus 0.026 μM tacr). GAPDH was used as loading control.